Zevra Denmark Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZEVRA DENMARK, and what generic and branded alternatives to ZEVRA DENMARK drugs are available?
ZEVRA DENMARK has one approved drug.
Drugs and US Patents for Zevra Denmark
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zevra Denmark | MIPLYFFA | arimoclomol citrate | CAPSULE;ORAL | 214927-004 | Sep 20, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Zevra Denmark | MIPLYFFA | arimoclomol citrate | CAPSULE;ORAL | 214927-002 | Sep 20, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Zevra Denmark | MIPLYFFA | arimoclomol citrate | CAPSULE;ORAL | 214927-003 | Sep 20, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.